WesBanco Bank’s Lisata Therapeutics LSTA Stock Holding History

WesBanco Bank’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$18K	Hold	667	–	–	﹤0.01%	510
2020 Q2	$18K	Hold	667	–	–	﹤0.01%	504
2020 Q1	$18K	Hold	667	–	–	﹤0.01%	476
2019 Q4	$25K	Hold	667	–	–	﹤0.01%	520
2019 Q3	$26K	Hold	667	–	–	﹤0.01%	513
2019 Q2	$23K	Hold	667	–	–	﹤0.01%	519
2019 Q1	$36K	Buy	+667	New	+$43.8K	﹤0.01%	518

Other funds holding LSTA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WesBanco Bank's LSTA Position: Q3 2020 in Review

WesBanco Bank held its Lisata Therapeutics (LSTA) position steady in Q3 2020 at 667 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #510.

WesBanco Bank first reported a position in LSTA in Q1 2019 and has held it in 7 quarters since. The position peaked at $36K in Q1 2019. 32 funds tracked by Wall St. Rank hold LSTA as of Q3 2020.

WesBanco Bank held 667 shares of Lisata Therapeutics worth $18K as of Q3 2020.
WesBanco Bank left its Lisata Therapeutics share count unchanged in Q3 2020.
Lisata Therapeutics made up ﹤0.01% of WesBanco Bank's portfolio in Q3 2020, its #510 holding.
WesBanco Bank first reported a position in Lisata Therapeutics in Q1 2019 and has held it in 7 quarters since.
WesBanco Bank's Lisata Therapeutics position peaked at $36K in Q1 2019.
32 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2020.

Based on WesBanco Bank's 13F filing for Q3 2020, filed 13 Nov 2020.